Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) are the standard agents for treating patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative advanced breast ...
Although chimeric antigen receptor (CAR) T cell therapy is highly efficacious in relapsed/refractory multiple myeloma (RRMM), both durations of remissions and toxicities can be highly variable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results